Deutz Buy, Astrazeneca's Trial, Computacenter Up
from Stock Movers Hosted by iHeartPodcasts
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Deutz agreed to buy military vehicle maker Flensburger Fahrzeugbau Gesellschaft mbH for €1.6 billion ($1.8 billion), expanding further into the defense sector to benefit from Europe’s rearmament drive. - AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped. - Computacenter expects first-half adjusted profit before tax to be double the prior year’s first-half figure of £81.5m, following 2Q performance ahead of expectations.
Embed this episode
No transcript yet.